To Evaluate the Effect of Clarithromycin on the Systemic Exposure of Pacritinib in Healthy Subjects

NCT02807051 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Drug Interaction Study

Interventions

DRUG: Pacritinib
DRUG: Clarithromycin
DRUG: Pacritinib and Clarithromycin

Sponsor

CTI BioPharma

Collaborators

[object Object]